Mangalam Drugs & Organics Profit & Loss Annual

BSE: 532637 | NSE: MANGALAM | ISIN: INE584F01014 | Sector: Biotechnology & Drugs

105.85 -1.05 (-0.98%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	368.59	372.25	451.07	380.14
Total Revenue	368.59	372.25	451.07	380.14
Costof Revenue Total	244.51	280.71	334.10	251.78
Gross Profit	124.08	91.55	116.97	128.36
Selling/ General/ Admin Expenses Total	39.07	64.96	65.97	75.03
Depreciation/ Amortization	14.65	10.99	10.25	9.18
Other Operating Expenses Total	67.61	1.06	1.95	-
Total Operating Expense	365.85	357.72	412.26	335.99
Operating Income	2.75	14.53	38.81	44.15
Interest Inc( Exp) Net- Non- Op Total	-139.17	-86.23	-71.13	-63.21
Other Net	0.10	-3.69	-3.96	1.72
Net Income Before Taxes	-11.07	2.21	27.73	39.52
Provisionfor Income Taxes	-2.00	0.94	8.08	11.55
Net Income After Taxes	-9.07	1.27	19.66	27.97
Net Income Before Extra Items	-9.07	1.27	19.66	27.97
Net Income	-9.07	1.27	19.66	27.97
Income Availableto Com Excl Extra Ord	-9.07	1.27	19.66	27.97
Income Availableto Com Incl Extra Ord	-9.07	1.27	19.66	27.97
Diluted Net Income	-9.07	1.27	19.66	27.97
Diluted Weighted Average Shares	1.58	1.58	1.58	1.58
Diluted EPS Excluding Extra Ord Items	-5.73	0.80	12.42	17.67
Diluted Normalized EPS	-5.73	0.80	12.42	17.69
Gain( Loss)on Saleof Assets	-	-0.03	-	-0.30
Unusual Expense( Income)	-	-	0.00	-
Total Adjustmentsto Net Income	-	-	-	0.00